- Home
- EAT vs PCVX Comparison
EAT vs PCVX Comparison
Compare EAT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EAT | PCVX |
|---|---|---|
| Founded | 1975 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.1B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EAT | PCVX |
|---|---|---|
| Price | $147.05 | $55.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 7 |
| Target Price | ★ $184.59 | $98.33 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 144.71 | N/A |
| EPS | ★ 5.03 | N/A |
| Revenue | ★ $5,384,200,000.00 | N/A |
| Revenue This Year | $9.02 | N/A |
| Revenue Next Year | $5.45 | N/A |
| P/E Ratio | $30.11 | ★ N/A |
| Revenue Growth | ★ 21.95 | N/A |
| 52 Week Low | $100.30 | $28.09 |
| 52 Week High | $187.12 | $71.53 |
Technical Indicators
Market Signals| Indicator | EAT | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 48.67 |
| Support Level | $133.70 | $42.30 |
| Resistance Level | $154.19 | $56.04 |
| Average True Range (ATR) | 5.28 | 2.33 |
| MACD | 1.46 | -0.44 |
| Stochastic Oscillator | 71.74 | 38.22 |
Price Performance
Historical ComparisonAbout EAT Brinker International Inc.
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.